Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: Comparison with severe sepsis and septic shock

Intensive Care Medicine

Volumn 27, Issue 12, 2001, Pages 1853-1859

  Mavrommatis, A C ^a   Theodoridis, T ^a   Economou, M ^a   Kotanidou, A ^a   Ali, M E ^a   Christopoulou Kokkinou, V ^a   Zakynthinos, S G ^a  

^a GENERAL HOSPITAL OF NIKEA   (Greece)

Author keywords

Coagulation inhibitors; Fibrinolysis; Multiple organ dysfunction syndrome; Sepsis; Septic shock; Severe sepsis

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; BLOOD CLOTTING INHIBITOR; FIBRIN; FIBRINOGEN DEGRADATION PRODUCT; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FIBRINOLYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; SEPSIS; SEPTIC SHOCK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTOR INHIBITORS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 0035214178     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-001-1139-8     Document Type: Article

References (40)

1. Septic shock: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy
2. Increase in national hospital discharge survey rates for septicemia: United States, 1979-1987
3. Septic shock: Pathogenesis
4. The pathogenesis of sepsis
5. Modulators of coagulation. A critical appraisal of their role in sepsis
6. Disseminated intravascular coagulation
7. Coagulation, fibrinolysis, and kallikrein systems in sepsis: Relation to outcome
8. Protein C and S in severe infectious purpura of children: A collaborative study of 40 cases
9. Meningococcemia and purpura fulminans in adults: Acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates
10. A model for the interplay of inflammatory mediators in sepsis - A study in 48 patients
11. Fibrinolysis and coagulation in patients with infectious disease and sepsis
12. Protein C, protein S and C4b-binding protein in severe infection and septic shock
13. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans
14. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies
15. Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura
16. Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis
17. Time course of hemostatic abnormalities in sepsis and its relation to outcome
18. Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality
19. Factor Vlla and antithrombin III activity during severe sepsis and septic shock in neutropenic patients
20. Definitions for sepsis and guidelines for the use of innovative therapies in sepsis
21. Time course and prognostic significance of hemostatic changes in sepsis: Relation to tumor necrosis factor-a
22. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
23. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo
24. Endotoxin-induced intravascular coagulation in rabbits. Effects of tissue plasminogen activator vs urokinase an PAI generation, fibrin deposits and mortality
25. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: Studies in nonhuman primates after interleukin-1a administration and during lethal bacteremia
26. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades
27. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
28. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
29. Tumor necrosis factor infusions have a procoagulant effect an the hemostatic mechanism in humans
30. Fibrinolytic response to tumor necrosis factor in healthy subjects
31. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever
32. Coagulation system and platelets are fully activated in uncomplicated sepsis
33. APACHE II: A severity of disease classification system
34. Multiple organ dysfunction score: Reliable descriptor of a complex clinical outcome
35. A simple sequentially rejective multiple test procedure
36. Blood coagulation and fibrinolysis
37. Plasminogen: An important hemostatic parameter in septic patients
38. Plasminogen activator inhibitor 1: A new prognostic marker in septic shock
39. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock
40. Efficacy and safety of recombinant human activated protein C for severe sepsis